Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Diversa Corporation (NasdaqNM:DVSA)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials | Reports
Location
4955 Directors Place
San Diego, CA 92121
Phone: (800) 523-2990
Email: information@diversa.com
Employees (last reported count): 200
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Free Annual Report
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Investor Relations
 ·Employment
 ·Products & Services
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 56%
·Over the last 6 months:
 · 5 insider buys; 849.0K shares (4.5% of insider shares)
 · 7 insider sells; 132.0K shares
  (0.7% of insider shares)
·Institutional: 39% (88% of float)
(138 institutions)
·Net Inst. Buying: 2.61M shares (+16.04%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Diversa Corporation develops and applies proprietary technologies to discover and evolve novel genes and gene pathways from diverse environmental sources. The Company is utilizing its fully integrated approach to develop novel enzymes and other biologically active compounds, such as orally active drugs, produced by these genes and gene pathways. The Company's proprietary evolution technologies facilitate the optimization of genes found in nature to enable product solutions for the pharmaceutical, agricultural, chemical processing, and industrial markets. Within these broad markets, the Company is targeting key multi-billion dollar market segments where it believes its technologies and products will create high value and competitive advantages for strategic partners and customers.
More from Market Guide: Expanded Business Description

Financial Summary
Diversa Corporation is engaged in discovering and developing novel enzymes and other biologically active compounds from diverse environmental sources for use in agricultural, chemical processing, industrial and pharmaceutical applications. For the six months ended 6/30/01, total revenue rose 74% to $17 million. Net loss applicable to Common fell 35% to $4.3 million. Results reflect new and expanded collaborations, partially offset by higher R&D expenses.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

James Cavanaugh, Ph.D., 63
Chairman
--  --  
Jay Short, Ph.D., 42
Pres, CEO, Chief Technology Officer
$426K$100K
Karin Eastham, 51
Sr. VP- Fin., CFO and Sec.
567K--  
William Baum, 55
Sr. VP- Bus. Devel.
267K--  
R. Patrick Simms, 56
Sr. VP- Operations
232K1.8M
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:DVSAAs of 31-Aug-2001
Price and Volume
52-Week Low
on 22-Mar-2001
$9.50 
Recent Price$12.15 
52-Week High
on 3-Nov-2000
$30.50 
Daily Volume (3-month avg)194.0K
Daily Volume (10-day avg)192.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y]
52-Week Change-58.3%
52-Week Change
relative to S&P500
-44.0%
Share-Related Items
Market Capitalization$429.4M
Shares Outstanding35.3M
Float15.6M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$5.46 
Earnings (ttm)-$0.17 
Earnings (mrq)-$0.08 
Sales (ttm)$0.90 
Cash (mrq)$5.80 
Valuation Ratios
Price/Book (mrq)2.22 
Price/EarningsN/A 
Price/Sales (ttm)13.48 
Income Statements
Sales (ttm)$31.5M
EBITDA (ttm)-$14.6M
Income available to common (ttm)-$6.02M
Profitability
Profit Margin (ttm)-19.1%
Operating Margin (ttm)-58.9%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-2.61%
Return on Equity (ttm)-3.12%
Financial Strength
Current Ratio (mrq)12.68 
Debt/Equity (mrq)0.07 
Total Cash (mrq)$204.4M
Short Interest
As of 8-Aug-2001
Shares Short174.0K
Percent of Float1.1%
Shares Short
(Prior Month)
254.0K
Short Ratio1.11 
Daily Volume156.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.